Celiac Science
Celiac Drug Pipeline Gets a Win: Teva Reports Positive Phase 2a Results
Teva Pharmaceutical reports positive Phase 2a results for a celiac disease treatment, a welcome development in a pipeline that has seen repeated setbacks.